Article ID Journal Published Year Pages File Type
3353395 Immunity 2011 14 Pages PDF
Abstract

SummaryPrecise control of myeloid cell activation is required for optimal host defense. However, this activation process must be under exquisite control to prevent uncontrolled inflammation. Herein, we identify the Kruppel-like transcription factor 2 (KLF2) as a potent regulator of myeloid cell activation in vivo. Exposure of myeloid cells to hypoxia and/or bacterial products reduced KLF2 expression while inducing hypoxia inducible factor-1α (HIF-1α), findings that were recapitulated in human septic patients. Myeloid KLF2 was found to be a potent inhibitor of nuclear factor-kappaB (NF-κB)-dependent HIF-1α transcription and, consequently, a critical determinant of outcome in models of polymicrobial infection and endotoxemia. Collectively, these observations identify KLF2 as a tonic repressor of myeloid cell activation in vivo and an essential regulator of the innate immune system.

Graphical AbstractFigure optionsDownload full-size imageDownload high-quality image (428 K)Download as PowerPoint slideHighlights► KLF2 deficiency confers a proinflammatory phenotype to myeloid cells ► Myeloid KLF2 deficiency renders animals resistant to polymicrobial infection ► Myeloid KLF2 deficiency renders animals susceptible to endotoxic shock ► KLF2 negatively regulates the NF-κB-HIF-1α axis in macrophages

Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , , , , , , , , , , ,